Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed ...
2009 NOV 23 ... with some degree of risk reduction for each of the five histological subtypes except chronic myeloid leukemia. Risk reductions associated with high levels of vigorous activity were ...
2009 NOV 23 ... analyses in the assessment of imatinib mesylate response in patients suffering the chronic phase of chronic myelocytic leukemia who were refractory to a-interferon treatment. A ...
2009 NOV 23 ... represent the first tool permitting stable transduction of leukemic cancer cells, B-cell chronic lymphocytic leukemia cells, blocked in G(0)/G(1) early phase of the cell cycle. Thus, ...
2009 NOV 23 ... drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer ...
2009 NOV 17 ... developed grade II-IV acute graft-versus-host disease (GVHD) and 8 developed extensive chronic GVHD. With median follow-up of 39.1 months, event free survival and overall survival ... research from Seoul, South Korea, "We evaluate the outcomes in children with acute leukemia who received allogeneic hematopoietic stem cell transplantation (HCT) using unrelated ...
2009 NOV 23 ... important new results in indications such as multiple myeloma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia and myelodysplastic syndromes. ...
2009 NOV 23 ... last year with a rare type of blood cancer known as Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Kareem's cancer was diagnosed in November 2008 when a blood ...
2009 NOV 23 ... publish new data in the report 'BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.' "A number of single nucleotide polymorphisms (SNP) have been ...
2009 NOV 23 ... States report. "Here we report a case in which a patient with underlying chronic myelomonocytic leukemia was diagnosed with phlegmonous gastritis on biopsy. This ...
2009 NOV 23 ... in hematopoietic cells is unknown." "PRAME mRNA expression increased with chronic myeloid leukemia (CML) disease progression and its detection in late chronic-phase CML ...
2009 NOV 23 ... 3 most common subtypes: diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Height was positively associated with ...
2009 NOV 23 ... Current study results from the report, 'Overcoming resistance in chronic myelogenous leukemia,' have been published. "Chronic myeloid leukemia is defined by ...
2009 NOV 23 ... regulation and, if deregulated, in the development of neoplastic disorders including chronic lymphocytic leukemia (CLL). RNAs from primary cells of 50 treatment-naive CLL patients ...
2009 NOV 23 ... to 63% by Day 180. MDC predicted for a lower risk of acute (p=0.08) and particularly of chronic GVHD (p=0.01). MDC was not associated with subsequent relapse or TRM (p=0.67 and 0.72, ... from GVHD, but does not portend disease recurrence,' is newly published data in Leukemia & Lymphoma. "We analyzed the kinetics of CD3 chimerism in 120 consecutive allogeneic ...
2009 NOV 23 ... "Currently, limited molecular markers exist that can determine where in the spectrum of chronic myeloid leukemia (CML) progression an individual patient falls at diagnosis. Gene ...
2009 NOV 23 ... "A 51-year-old male was diagnosed with chronic phase chronic myeloid leukemia (CML) in May 2005. His Sokal score at diagnosis was 0.95 ...
2009 NOV 23 ... positive data from 1) an ongoing Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), and 2) a preclinical study demonstrating the effect of ...
2009 NOV 16 ... advance our clinical programs, including TRU-015 for rheumatoid arthritis, TRU-016 for chronic lymphocytic leukemia and SBI-087 for rheumatoid arthritis and systemic lupus ...
